Safety, tolerability and pharmacokinetic profile of Macozinone (PBTZ169) formulated as native crystal powder: multiple ascendingdoses, phase-Ib trial in healthy volunteers

Authors
Publication date
1 January 2022
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Serveur académique lausannois

    redirect
    oaioai:serval.unil.ch:BIB_F1F116F...
    Last time updated on 18/03/2023